top of page

Saving Lives
from Bleeding

A new paradigm in the treatment of acute haemorrhage.

ClotProtect are pioneering a new approach to tackle acute bleeding, with a first-in-class anti-fibrinolytic

ClotProtect is a therapeutics spin-out from the University of Leeds. Led by world-leading experts from industry and academia, we are developing a first in class small molecule anti-fibrinolytic to transform how acute bleeding is treated.

1.5M

Lives could be saved each year by the prevention of traumatic bleeding

a female surgeon undertaking a procedure in a cinical setting
A female surgeon undertaking a procedure in a clinical setting.

Small Molecule,
Enormous Potential

Unlike existing indirect treatment options, ClotProtect's approach promotes clot formation through a novel molecule and mechanism with superior efficacy and potency to the current standard of care.

Get in touch

If you wish to learn more about ClotProtect please contact us using the link below.

bottom of page